Lot-to-lot consistency, safety, tolerability and immunogenicity of an investigational hexavalent vaccine in US infants

Keyphrases

• Acellular Pertussis 10%
• Adverse Events 20%
• Antibody Response 10%
• Blood Specimen 10%
• Combination Vaccine 10%
• Diphtheria 10%
• Fever 10%
• Filamentous Hemagglutinin 10%
• Geometric Mean Concentration 20%
• Haemophilus Influenzae Type b 10%
• Healthy children 10%
• Hepatitis B 10%
• HepB 20%
• Hexavalent Vaccine 100%
• Immune Response 10%
• Immunogenicity 100%
• Inactivated Poliovirus Vaccine 10%
• Lot-to-lot Variability 100%
• Mandatory Vaccines 10%
• Manufacturing Consistency 10%
• New Combination 10%
• Pentavalent Rotavirus Vaccine 10%
• Pertactin 10%
• Pertussis 20%
• Phase II Study 10%
• Prevnar 13 20%
• Tetanus Toxoid 10%
• Toddlers 30%
• Tolerability 100%
• Vaccination 10%
• Vaccine Response 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 50%
• Combination Vaccine 25%
• Diphtheria Pertussis Poliomyelitis Tetanus Haemophilus Influenzae Type B Vaccine 25%
• Diphtheria Tetanus Toxoid 25%
• Haemophilus Influenzae Type B Vaccine 25%
• Hemagglutinin 25%
• Hepatitis B 25%
• Immunogenicity 100%
• Pertactin 25%
• Pertussis 75%
• Pneumococcus Vaccine 50%
• Poliomyelitis Virus 25%
• Recombinant Hepatitis B Vaccine 25%
• Rotavirus Vaccine 25%
• Tolerability 100%
• Vaccination Policy 25%

Immunology and Microbiology

• Antibody Response 7%
• Diphtheria Pertussis Poliomyelitis Tetanus Haemophilus Influenzae Type B Vaccine 7%
• Diphtheria Tetanus Toxoid 7%
• Hemagglutinin 7%
• Hepatitis B 7%
• Hib Vaccine 7%
• Immune Response 7%
• Immunogenicity 100%
• Monospecific Antibody 7%
• Pertactin 7%
• Pneumococcal Vaccine 15%
• Poliomyelitis Virus 7%
• Recombinant Hepatitis B Vaccine 7%
• Rotavirus Vaccine 7%
• Serotype 7%
• Vaccination Policy 7%
• Vaccine Efficacy 100%